Stay updated on LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The new screenshot shows no substantive updates to the study details; only minor layout/UI adjustments are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:31:52.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a version bump to v3.2.0; removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-12T16:49:48.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Updated the page from revision v3.0.2 to v3.1.0, signaling a new release version.
    Difference
    0.1%
    Check dated 2025-09-28T10:01:03.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page revision updates from v3.0.1 to v3.0.2, indicating a new release; the 'Back to Top' link has been removed, with no other substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-14T00:13:02.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T21:17:10.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has updated the facility name and location details, specifically changing from 'Gent, Belgium' to 'Ghent, Belgium'. Additionally, there are updates to the drug names listed, with 'durvalumab' being retained and 'LY3022855' and 'tremelimumab' added.
    Difference
    1%
    Check dated 2025-08-30T15:45:50.000Z thumbnail image

Stay in the know with updates to LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page.